Neoadjuvant and Adjuvant Chemotherapy for Advanced Ovarian Cancer, Including Biological Agents
Study N Study population Treatment arms PFS (months) OS (months) GOG 111 410 Stage III with residual disease >1 cm after initial surgery or stage IV disease Cisplatin (75 mg/m2)/Cyclophosphamide…